Sfoglia per Autore
Selective SERCA2a activator as a candidate for chronic heart failure therapy
2024 Arici, M; Hsu, S; Ferrandi, M; Barassi, P; Ronchi, C; Torre, E; Luraghi, A; Chang, G; Ferrari, P; Bianchi, G; Peri, F; Zaza, A; Rocchetti, M
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies
2024 Franco, A; Sadones, O; Romerio, A; Artusa, V; Shaik, M; Pasco, S; Italia, A; D'Amato, S; Anguita, J; Huebner, J; Romero-Saavedra, F; Peri, F
A new advanced cellular model of functional cholinergic-like neurons developed by reprogramming the human SH-SY5Y neuroblastoma cell line
2024 D'Aloia, A; Pastori, V; Blasa, S; Campioni, G; Peri, F; Sacco, E; Ceriani, M; Lecchi, M; Costa, B
Potentiation of fluoroquinolone and macrolide activities by efflux pump inhibitory effect on Staphylococcus aureus and Streptococcus pyogenes of new benzyl piperazinyl lysine derivatives
2023 Musumeci, R; Martinelli, M; Giubbi, C; Perdoni, F; Romerio, A; Vertemara, J; De Gioia, L; Peri, F; Cocuzza, C
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants
2023 Romerio, A; Gotri, N; Franco, A; Artusa, V; Shaik, M; Pasco, S; Atxabal, U; Matamoros-Recio, A; Minguez-Toral, M; Zalamea, J; Franconetti, A; Abrescia, N; Jimenez-Barbero, J; Anguita, J; Martin-Santamaria, S; Peri, F
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
2023 Arici, M; Ferrandi, M; Barassi, P; Hsu, S; Torre, E; Luraghi, A; Ronchi, C; Chang, G; Peri, F; Ferrari, P; Bianchi, G; Rocchetti, M; Zaza, A
Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory
2023 Artusa, V; Calabrone, L; Mortara, L; Peri, F; Bruno, A
Use of Fluorescent Chemical Probes in the Study of Toll-like Receptors (TLRs) Trafficking
2023 Franco, A; Artusa, V; Peri, F
A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice
2023 Balu, D; Valencia-Olvera, A; Nguyen, A; Patnam, M; York, J; Peri, F; Neumann, F; Ladu, M; Tai, L
Cleaner synthesis of preclinically validated vaccine adjuvants
2023 Romerio, A; Peri, F
Emerging Extracellular Molecular Targets for Innovative Pharmacological Approaches to Resistant Mtb Infection
2023 Italia, A; Shaik, M; Peri, F
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity
2023 Romerio, A; Franco, A; Shadrick, M; Shaik, M; Artusa, V; Italia, A; Lami, F; Demchenko, A; Peri, F
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure
2022 Luraghi, A; Ferrandi, M; Barassi, P; Arici, M; Hsu, S; Torre, E; Ronchi, C; Romerio, A; Chang, G; Ferrari, P; Bianchi, G; Zaza, A; Rocchetti, M; Peri, F
A Global Picture of Molecular Changes Associated to LPS Treatment in THP-1 Derived Human Macrophages by Fourier Transform Infrared Microspectroscopy
2022 Ami, D; Franco, A; Artusa, V; Mereghetti, P; Peri, F; Natalello, A
Green and Roasted Coffee Extracts Inhibit Interferon-β Release in LPS-Stimulated Human Macrophages
2022 Artusa, V; Ciaramelli, C; D’Aloia, A; Facchini, F; Gotri, N; Bruno, A; Costa, B; Palmioli, A; Airoldi, C; Peri, F
NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR
2021 Peri, F; Romerio, A; D'Amato, S
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells
2021 Tisi, R; Spinelli, M; Palmioli, A; Airoldi, C; Cazzaniga, P; Besozzi, D; Nobile, M; Mazzoleni, E; Arnhold, S; De Gioia, L; Grandori, R; Peri, F; Vanoni, M; Sacco, E
Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and in Vivo Activity
2021 Facchini, F; Minotti, A; Luraghi, A; Romerio, A; Gotri, N; Matamoros-Recio, A; Iannucci, A; Palmer, C; Wang, G; Ingram, R; Martin-Santamaria, S; Pirianov, G; De Andrea, M; Valvano, M; Peri, F
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants
2021 Franco, A; Peri, F
Electrospinning for drug delivery applications: A review
2021 Luraghi, A; Peri, F; Moroni, L
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile